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Ventricular assist device (VAD) related infection, specifically driveline infection, is a
common complication after VAD implantation. A 45-year old patient with a delayed
skin infection at the site of the original driveline nearly one year after VAD
inactivation and surgical driveline burial was treated with antibiotics and surgical
debridement for approximately six months. Continued discharge at driveline site
and growth of methicillin susceptible Staphylococcus aureus resulted in the
recommendation of explantation of the VAD. Post-VAD explantation, the patient
remains symptom free and without infection 21 months following explant.
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Case Report
Device-related infections, specifically driveline infections, are a common
complication after ventricular assist device (VAD) implantation. Reported infections
have been in patients with functional pumps and percutaneous drivelines. We
present a case of a patient with delayed skin infection at the site of the original
driveline nearly one year after VAD inactivation and surgical driveline burial.
A 45-year-old man with ischemic cardiomyopathy underwent HeartMate II (Abbott)
implantation as bridge-to-transplant intervention. His post-VAD course was
complicated by recurrent gastrointestinal bleeding. He was noncompliant, desired
non-traditional therapies and ultimately elected to discontinue anticoagulation,
resulting in pump thrombosis. Echocardiogram revealed minimal myocardial
recovery with persistent severe left ventricular dysfunction (ejection fraction ~
10%). He was considered too high risk for VAD explantation. The VAD was
inactivated, and inflow cannula and outflow grafts were left in situ. The driveline
was severed and surgically buried. The incision was closed and healed
completely. After 11 months, he presented with 3 weeks of local irritation and
drainage at the old driveline exit site, which was exacerbated by his persistent
digital manipulation of the area. Oral antibiotic therapy was initiated; however, the
infection persisted. Local debridement revealed a wire from the driveline in the
wound bed (Figure 1).

Figure 1. Evolution of the wound is displayed. (a) Initial encounter after driveline
burial with scant purulent drainage is seen. (b) Purulent exist site infection
approximately 11 months later. (c) Driveline remnant from wound. (d) Recurrent
purulent infection just prior to VAD explant at 17 months post-implant.
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Operative wound cultures grew methicillin susceptible Staphylococcus aureus
(MSSA). The patient was admitted twice in the subsequent six months for
intravenous antibiotics and surgical debridement. Wound cultures repeatedly
demonstrated MSSA. He declined palliative care and withdrawal of medical care;
thus, due to persistent infection despite aggressive treatment, we recommended
device removal for source control (Figure 2).

Figure 2. (a) Chest x-ray with Heartmate II driveline remnant (arrow). (b) Chest xray after Heartmate II explant.

During the procedure, the driveline exit site wound was found to be communicating
with the VAD pocket. Copious amounts of purulent material was encountered in
the VAD pocket and on the inflow and outflow grafts. Blood cultures were negative;
and MSSA grew from intraoperative tissue and the explanted VAD. The patient is
currently infection free, New York Heart Association Class III, 21 months post-VAD
explant.

Discussion
Ventricular assist devices prolong survival for patients with end-stage heart failure;
however, complications associated with infection have presented major challenges
(1). Current VAD technology requires a percutaneous driveline power supply,
which may serve as a port of entry for infectious organisms. Infection is noted as
the fourth most common cause of death in patients with mechanical circulatory
support devices, accounting for 8.8% of deaths (2). In addition, driveline infections
make up approximately 83% of infections directly related to device hardware (1,2).
The International Society for Heart and Lung Transplantation issued a consensus
statement with recommendations to guide management of infection in patients with
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mechanical circulatory support devices (3). However, there is no consensus
regarding management of the driveline after deactivation. This case represents the
devastating consequences suffered as a result of a severe ascending driveline and
pump infection and emphasizes the importance of continued patient education and
monitoring in this unique scenario. In addition, this highlights the need to develop
guidelines for the management of patients who develop VAD-related complications
who are not candidates for VAD exchange or heart transplantation and fail to
achieve myocardial recovery.
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